Works matching IS 11732563 AND DT 2021 AND VI 41 AND IP 5
Results: 11
Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 5, p. 459, doi. 10.1007/s40261-021-01023-8
- By:
- Publication type:
- Article
Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 5, p. 415, doi. 10.1007/s40261-021-01021-w
- By:
- Publication type:
- Article
Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 5, p. 449, doi. 10.1007/s40261-021-01018-5
- By:
- Publication type:
- Article
Correction to: Efficacy of Collagenase Clostridium histolyticum (Xiapex®) in Patients with the Acute Phase of Peyronie's Disease.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 5, p. 425, doi. 10.1007/s40261-021-01032-7
- By:
- Publication type:
- Article
Authors' Reply to 'Comment on: Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials'.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comment on 'Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III trials'.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 5, p. 437, doi. 10.1007/s40261-021-01028-3
- By:
- Publication type:
- Article
First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 5, p. 469, doi. 10.1007/s40261-021-01027-4
- By:
- Publication type:
- Article
Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Letter